Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Chapman

Showing results (1141-1150 of 1,208) with videos related to

Pageof 121
Sort By:
Journal of the American Chemical Society|July 25, 2022
Densified HKUST-1 Monoliths as a Route to High Volumetric and Gravimetric Hydrogen Storage CapacityDavid Gerard Madden, Daniel O'Nolan, Nakul Rampal, et al.
Breast Cancer Research and Treatment|June 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozoleJudith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus AnastrozoleJudith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31Karen A Gelmon, Frances M Boyle, Bella Kaufman, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Nature Materials|March 7, 2018
A molecular cross-linking approach for hybrid metal oxidesDahee Jung, Liban M A Saleh, Zachariah J Berkson, et al.
Nature Materials|March 18, 2018
Publisher Correction: A molecular cross-linking approach for hybrid metal oxidesDahee Jung, Liban M A Saleh, Zachariah J Berkson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing CholangitisCharlotte Rose Hawkey Hedin, Gina Sado, Nelson Ndegwa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsJohn H Rex, Peter G Pappas, Adolf W Karchmer, et al.
Pageof 121

Showing results (1141-1150 of 1,208) with videos related to

Sort By:
Pageof 121
Journal of the American Chemical Society|July 25, 2022
Densified HKUST-1 Monoliths as a Route to High Volumetric and Gravimetric Hydrogen Storage CapacityDavid Gerard Madden, Daniel O'Nolan, Nakul Rampal, et al.
Breast Cancer Research and Treatment|June 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozoleJudith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus AnastrozoleJudith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31Karen A Gelmon, Frances M Boyle, Bella Kaufman, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Nature Materials|March 7, 2018
A molecular cross-linking approach for hybrid metal oxidesDahee Jung, Liban M A Saleh, Zachariah J Berkson, et al.
Nature Materials|March 18, 2018
Publisher Correction: A molecular cross-linking approach for hybrid metal oxidesDahee Jung, Liban M A Saleh, Zachariah J Berkson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing CholangitisCharlotte Rose Hawkey Hedin, Gina Sado, Nelson Ndegwa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsJohn H Rex, Peter G Pappas, Adolf W Karchmer, et al.
Pageof 121